Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
J Public Health (Oxf) ; 45(2): 491-498, 2023 Jun 14.
Article in English | MEDLINE | ID: mdl-35312006

ABSTRACT

BACKGROUND: Lockdown, as a measure implemented to combat the coronavirus disease 2019 (COVID-19) pandemic, left many domestic violence (DV) victims trapped with their abusers. This study intends to explore the links between perceived stress, substance use and socio-demographic factors with DV experiences during COVID-19 pandemic in Portugal. METHODS: A cross-sectional study was carried out on a sample of 1062 participants over 16 years old, residing in Portugal. Data were collected through an online survey conducted between April and October 2020. The associations between potential factors and DV were investigated using bivariable analysis and multivariable logistic regression. RESULTS: The prevalence of DV reported was 13.75% (n = 146), disaggregated into psychological violence (13%, n = 138), sexual violence (1.0%, n = 11) and physical violence (0.9%, n = 10). Multivariable analyses confirmed that perceived financial difficulties (OR = 1.608; P = 0.019), use of medications to sleep or calm down (OR = 1.851; P = 0.002) and perceived stress (OR = 2.443; P = 0.003) were responsible for DV exposure during COVID-19 pandemic. Younger age (<25 years old) and consumption of alcohol were associated with a higher risk of DV victimization. CONCLUSIONS: Interventions aimed at preventing and confronting DV are necessary within the strategies to combat COVID-19 in Portugal, especially aimed at groups in vulnerable situations, during and after the pandemic.


Subject(s)
COVID-19 , Domestic Violence , Substance-Related Disorders , Humans , Adult , Adolescent , Pandemics , Portugal/epidemiology , Cross-Sectional Studies , COVID-19/epidemiology , Communicable Disease Control , Domestic Violence/psychology , Substance-Related Disorders/epidemiology , Demography
2.
Sci Rep ; 12(1): 22520, 2022 12 29.
Article in English | MEDLINE | ID: mdl-36581649

ABSTRACT

Although universal biometrics have been broadly called for, and there are many validated technologies to recognize adults, these technologies have been ineffective in newborns and young children. The present work describes the development and clinical testing of a fingerprint capture system for longitudinal biometric recognition of newborns and young children to support vaccination and clinical follow-up. The reader consists of a high-resolution monochromatic imaging system with an ergonomic industrial design to comfortably support and align infant fingers for imaging without a platen. This imaging approach without a platen, also called free-space imaging, reduces fingerprint distortion and ensures a more consistent finger placement. This system was tested in a newborn ward and immunization clinic at an urban hospital in Baja, California, Mexico, from 2017 to 2019. Nearly five hundred children were enrolled and followed for up to 24 months. With a protocol of imaging all ten fingers, the failure to enroll (FTE) rate was < 1% when acquiring at least two fingers for all ages and < 2% when enrolling at least four fingers. The verification (1:1) true accept rate (TAR) was 77% for newborns enrolled at ≤ 3 days of age and 96% for those enrolled at ≥ 4 days of age, both at a time gap of 15-30 days after enrollment at a false accept rate (FAR) of 0.1%. Using the top-ranked match score, the identification rate (1:many) was 86% for the ≤ 3 days enrollment age and 97% for age ≥ 4 days for a single finger at 15-30 days after enrollment. The enrollment protocol and the frequency of updating will increase for infants compared to adults. However, these data suggest that a high-resolution, free space imaging technique may fill the final gap for universal biometrics across all populations called for by the United Nations Sustainable Development Goal 16.9.


Subject(s)
Biometry , Hospitals, Urban , Infant , Adult , Humans , Infant, Newborn , Child , Child, Preschool , Prospective Studies , Delivery of Health Care , Vaccination
3.
ACS Omega ; 7(45): 40844-40852, 2022 Nov 15.
Article in English | MEDLINE | ID: mdl-36406489

ABSTRACT

The increasing demand for solar energy has led researchers worldwide to develop new photovoltaic technologies. Among these, perovskite materials are one of the most promising candidates, with a performance evolution unparalleled in the photovoltaic field. However, this thin-film technology is not yet available at a commercial level, mainly due to upscaling issues. This work studied the best design options for upscaling single cells into modules by minimizing electrical losses in the device substrates. The software LAOSS was used to test and optimize different substrate sizes and designs and to predict several performance outcomes from experimentally fabricated single cells. The results showed that it is possible to retain most of the energy production when upscaling from a single cell to a module if the appropriate design for an efficient monolithic device is used. The width of the interconnection zone also plays an important role in device performance and must be carefully optimized during module design. It then demonstrates the importance of having precise laser tools, which are essential for narrow and smooth scribes, and how useful simulation software can be, which, combined with experimental developments, will facilitate efficient module fabrication, aiming to establish it as a feasible and marketable resource.

4.
Article in English | MEDLINE | ID: mdl-35682079

ABSTRACT

The social conditions created by the COVID-19 pandemic had a great potential to affect the mental health of individuals. Meta-analyses indicate a rise in these problems in these periods among general populations, patients and health professionals, even with substantial heterogeneous results. This paper examines mental health impacts specifically during the first wave of COVID-19. An online survey was conducted with a Portuguese convenience sample (N = 1.062) comprising questions about substance use, perceived stress, post-traumatic stress disorder and self-damage behaviors. The results concerning substance use show an extensive use of medication to sleep or calm down, especially among women and older respondents, a small percentage of alcohol consumers with a high pattern of use and less frequent cannabis consumption, even with a quarter of users who began only in the COVID-19 period. The rates of perceived stress and PTSD were higher compared with international prevalence estimations during the pandemic conditions. Both correlated measures were worse for women and young people. Another problematic issue was the rate of suicidal ideation, with a relevant proportion of starters during this period. These data reinforce the need to promote access to mental health services.


Subject(s)
COVID-19 , Substance-Related Disorders , Adolescent , COVID-19/epidemiology , Female , Humans , Mental Health , Pandemics , Portugal/epidemiology , SARS-CoV-2
5.
Arch Cardiol Mex ; 90(4): 503-510, 2020.
Article in Spanish | MEDLINE | ID: mdl-33373357

ABSTRACT

El síndrome cardiorrenal (SCR) es un trastorno en el que intervienen el corazón y los riñones, interactuando y produciendo una disfunción entre ellos en forma aguda o crónica. Existen diferentes fenotipos clínicos bien identificados como «desórdenes del corazón y riñón en los que la disfunción aguda o crónica en un órgano induce la disfunción aguda o crónica del otro¼. La alta incidencia de morbimortalidad cardiovascular presente en los pacientes con enfermedad renal crónica terminal (ERCT), en especial la insuficiencia cardiaca (IC), origina inicialmente una lesión miocárdica que conlleva remodelamiento ventricular, lo cual induce a la activación de mecanismos compensadores, entre los cuales el riñón es pieza fundamental, ya que regula la homeostasis hidroelectrolítica y así el volumen circulante, siendo esto en la etapa dialítica más evidente. Los cambios funcionales y anatómicos cardiovasculares que se producen en estos pacientes son muy prevalentes e incluyen las interacciones hemodinámicas del corazón y los riñones en la insuficiencia cardiaca, y el impacto de la enfermedad aterosclerótica en ambos sistemas de órganos. También describimos estrategias diagnósticas y terapéuticas aplicables al síndrome cardiorrenal, que determinan la importancia de la ecocardiografía como modelo de diagnóstico útil. Finalmente, se analizan las posibilidades de tratamiento y la remisión de las alteraciones funcionales cardiacas con el trasplante renal en los pacientes con ERCT.Cardiorenal syndrome (CRS) is a disorder in which the heart and kidneys are involved, interacting and producing a dysfunction between them in an acute or chronic way. There are different clinical phenotypes well identified as "heart and kidney disorders in which acute or chronic dysfunction in one organ induces acute or chronic dysfunction in the other". The high incidence of cardiovascular morbimortality in patients with chronic terminal kidney disease (CKD), especially heart failure (HF), initially causes a myocardial lesion that leads to ventricular remodeling, which induces the activation of compensatory mechanisms, among which the kidney is a fundamental part since it regulates the hydroelectrolytic homeostasis and thus the circulating volume, being this in the dialytic stage more evident. The functional and anatomical changes at cardiovascular level that occur in these patients are very prevalent, and include hemodynamic interactions of the heart and kidneys in heart failure and the impact of atherosclerotic disease in both organ systems. We also describe diagnostic and therapeutic strategies applicable to cardiorenal syndrome, which determine the importance of echocardiography as a useful diagnostic model. Finally, we analyze the possibilities of treatment and remission of cardiac functional alterations with renal transplantation in patients with T-CKD.


Subject(s)
Cardio-Renal Syndrome/diagnostic imaging , Echocardiography , Kidney Failure, Chronic/complications , Cardio-Renal Syndrome/physiopathology , Humans , Kidney Failure, Chronic/diagnostic imaging , Kidney Failure, Chronic/surgery , Kidney Transplantation
6.
Arch. cardiol. Méx ; 90(4): 503-510, Oct.-Dec. 2020. graf
Article in Spanish | LILACS | ID: biblio-1152826

ABSTRACT

Resumen El síndrome cardiorrenal (SCR) es un trastorno en el que intervienen el corazón y los riñones, interactuando y produciendo una disfunción entre ellos en forma aguda o crónica. Existen diferentes fenotipos clínicos bien identificados como «desórdenes del corazón y riñón en los que la disfunción aguda o crónica en un órgano induce la disfunción aguda o crónica del otro¼. La alta incidencia de morbimortalidad cardiovascular presente en los pacientes con enfermedad renal crónica terminal (ERCT), en especial la insuficiencia cardiaca (IC), origina inicialmente una lesión miocárdica que conlleva remodelamiento ventricular, lo cual induce a la activación de mecanismos compensadores, entre los cuales el riñón es pieza fundamental, ya que regula la homeostasis hidroelectrolítica y así el volumen circulante, siendo esto en la etapa dialítica más evidente. Los cambios funcionales y anatómicos cardiovasculares que se producen en estos pacientes son muy prevalentes e incluyen las interacciones hemodinámicas del corazón y los riñones en la insuficiencia cardiaca, y el impacto de la enfermedad aterosclerótica en ambos sistemas de órganos. También describimos estrategias diagnósticas y terapéuticas aplicables al síndrome cardiorrenal, que determinan la importancia de la ecocardiografía como modelo de diagnóstico útil. Finalmente, se analizan las posibilidades de tratamiento y la remisión de las alteraciones funcionales cardiacas con el trasplante renal en los pacientes con ERCT.


Abstract Cardiorenal syndrome (CRS) is a disorder in which the heart and kidneys are involved, interacting and producing a dysfunction between them in an acute or chronic way. There are different clinical phenotypes well identified as "heart and kidney disorders in which acute or chronic dysfunction in one organ induces acute or chronic dysfunction in the other". The high incidence of cardiovascular morbimortality in patients with chronic terminal kidney disease (CKD), especially heart failure (HF), initially causes a myocardial lesion that leads to ventricular remodeling, which induces the activation of compensatory mechanisms, among which the kidney is a fundamental part since it regulates the hydroelectrolytic homeostasis and thus the circulating volume, being this in the dialytic stage more evident. The functional and anatomical changes at cardiovascular level that occur in these patients are very prevalent, and include hemodynamic interactions of the heart and kidneys in heart failure and the impact of atherosclerotic disease in both organ systems. We also describe diagnostic and therapeutic strategies applicable to cardiorenal syndrome, which determine the importance of echocardiography as a useful diagnostic model. Finally, we analyze the possibilities of treatment and remission of cardiac functional alterations with renal transplantation in patients with T-CKD.


Subject(s)
Humans , Echocardiography , Cardio-Renal Syndrome/diagnostic imaging , Kidney Failure, Chronic/complications , Kidney Transplantation , Cardio-Renal Syndrome/physiopathology , Kidney Failure, Chronic/surgery , Kidney Failure, Chronic/diagnostic imaging
7.
PLoS One ; 15(11): e0238676, 2020.
Article in English | MEDLINE | ID: mdl-33151929

ABSTRACT

We showed the results of the first long-term analysis (1987-2019) of pesticide (herbicides, fungicides and insecticides) impact in the Rolling Pampa, one of the main agricultural areas of Argentina. Using a clear and meaningful tool, based not only on acute toxicity but also on scaling up the results to total sown area, we identified time trends for both pesticide impact and the ecoefficiency of modal pesticide profiles. By the end of the time series, soybean showed a pesticide impact four times greater than maize crop in the studied area. However, the time trend in the subperiod (2012-2019) showed a sustainable pattern of pesticide use in soybean crop, with an improvement in its ecoefficiency. Oppositely, maize showed a relatively constant ecoefficiency value during most of the time series, suggesting a possible path towards an unsustainable cropping system. Findings from this study suggest that some efforts have to be made to improve the pest management decisions towards a more efficient pesticide profiles in maize crop and to keep improving the ecotoxicity pesticide profile in soybean crops because of its large sown area in the studied area.


Subject(s)
Crops, Agricultural/drug effects , Pesticides/adverse effects , Agriculture/methods , Argentina , Ecotoxicology/methods , Environmental Monitoring/methods , Fungicides, Industrial/adverse effects , Herbicides/adverse effects , Insecticides/adverse effects , Pest Control/methods , Glycine max/drug effects , Zea mays/drug effects
8.
Arch Cardiol Mex ; 90(3): 284-292, 2020.
Article in English | MEDLINE | ID: mdl-32952159

ABSTRACT

Introducción: El deterioro cognitivo leve es una alteración de la función cognitiva que no afecta de manera negativa a las actividades diarias de la persona. Factores de riesgo modificables como la hipertensión arterial podrían intervenir en el aceleramiento de este proceso y afectar a personas menores de 65 años. Una detección temprana del deterioro cognitivo leve por medio del Montreal Cognitive Assesment (MoCA) en personas con hipertensión arterial ayudaría a idear medidas para su control eficaz. Materiales y métodos: Se diseñó un estudio de tipo observacional transversal. La población se integra con pacientes hipertensos de 45 a 65 años de Guayaquil. De una base de datos de 570 pacientes, se realizó un llamado a sujetos que cumplieran los criterios de inclusión y exclusión, para la evaluación de la función cognitiva por medio del MoCA. Resultados: El 93.3% de los participantes sometidos a la prueba MoCA presentó un puntaje menor de 26. El promedio del puntaje total fue de 18.9 y el 51.6% de los participantes reveló deterioro cognitivo leve. Se obtuvo una correlación negativa del 40% (-0.40) con una p = 0.0015 entre años con hipertensión arterial y el resultado total de la prueba MoCA. Conclusiones: Por medio del MoCA se pudo cuantificar la magnitud del deterioro cognitivo en estos pacientes. Se identificó que la mayoría de los participantes examinados presentaba un puntaje promedio menor del intervalo normal. Las cifras obtenidas de los valores de correlación de Pearson muestran una actividad tendencial y relación de la hipertensión arterial con el deterioro de la función cognitiva. Introduction: Mild cognitive impairment is an alteration of cognitive function that does not negatively affect the daily activities of the person. Modifiable risk factors such as hypertension could be involved in the acceleration of this process affecting people under 65 years of age. Early detection of mild cognitive impairment through the Montreal Cognitive Assessment (MoCA) in people with high blood pressure, would help to formulate strategies for its effective control. Materials and methods: A cross-sectional observational study was designed. The population is hypertensive patients between 45 and 65 years old in Guayaquil. From a database of 570 patients, a call was made to patients who met the inclusion and exclusion criteria, for the evaluation of cognitive function through MoCA. Results: 93.3% of the participants who underwent the MoCA test had a score lower than 26. The average of the total score was 18.9, with 51.6% of the participants suffering from mild cognitive impairment. A negative correlation of 40% (-0.40) was obtained with a p = 0.0015 between years with arterial hypertension and the total result of the MoCA test. Conclusions: Through MoCA, the magnitude of cognitive deterioration in these patients could be quantified. It was detected that the majority of the examined participants had a lower average score of the normal range. The figures obtained from the Pearson correlation values show trend activity, relating arterial hypertension and deterioration of cognitive function.


Subject(s)
Cognition/physiology , Cognitive Dysfunction/diagnosis , Hypertension/complications , Aged , Cognitive Dysfunction/epidemiology , Cognitive Dysfunction/etiology , Cross-Sectional Studies , Ecuador , Female , Humans , Male , Middle Aged , Risk Factors
9.
Arch. cardiol. Méx ; 90(3): 284-292, Jul.-Sep. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1131045

ABSTRACT

Resumen Introducción: El deterioro cognitivo leve es una alteración de la función cognitiva que no afecta de manera negativa a las actividades diarias de la persona. Factores de riesgo modificables como la hipertensión arterial podrían intervenir en el aceleramiento de este proceso y afectar a personas menores de 65 años. Una detección temprana del deterioro cognitivo leve por medio del Montreal Cognitive Assesment (MoCA) en personas con hipertensión arterial ayudaría a idear medidas para su control eficaz. Materiales y métodos: Se diseñó un estudio de tipo observacional transversal. La población se integra con pacientes hipertensos de 45 a 65 años de Guayaquil. De una base de datos de 570 pacientes, se realizó un llamado a sujetos que cumplieran los criterios de inclusión y exclusión, para la evaluación de la función cognitiva por medio del MoCA. Resultados: El 93.3% de los participantes sometidos a la prueba MoCA presentó un puntaje menor de 26. El promedio del puntaje total fue de 18.9 y el 51.6% de los participantes reveló deterioro cognitivo leve. Se obtuvo una correlación negativa del 40% (-0.40) con una p = 0.0015 entre años con hipertensión arterial y el resultado total de la prueba MoCA. Conclusiones: Por medio del MoCA se pudo cuantificar la magnitud del deterioro cognitivo en estos pacientes. Se identificó que la mayoría de los participantes examinados presentaba un puntaje promedio menor del intervalo normal. Las cifras obtenidas de los valores de correlación de Pearson muestran una actividad tendencial y relación de la hipertensión arterial con el deterioro de la función cognitiva.


Abstract Introduction: Mild cognitive impairment is an alteration of cognitive function that does not negatively affect the daily activities of the person. Modifiable risk factors such as hypertension could be involved in the acceleration of this process affecting people under 65 years of age. Early detection of mild cognitive impairment through the Montreal Cognitive Assessment (MoCA) in people with high blood pressure, would help to formulate strategies for its effective control. Materials and methods: A cross-sectional observational study was designed. The population is hypertensive patients between 45 and 65 years old in Guayaquil. From a database of 570 patients, a call was made to patients who met the inclusion and exclusion criteria, for the evaluation of cognitive function through MoCA. Results: 93.3% of the participants who underwent the MoCA test had a score lower than 26. The average of the total score was 18.9, with 51.6% of the participants suffering from mild cognitive impairment. A negative correlation of 40% (-0.40) was obtained with a p = 0.0015 between years with arterial hypertension and the total result of the MoCA test. Conclusions: Through MoCA, the magnitude of cognitive deterioration in these patients could be quantified. It was detected that the majority of the examined participants had a lower average score of the normal range. The figures obtained from the Pearson correlation values show trend activity, relating arterial hypertension and deterioration of cognitive function.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Cognition/physiology , Cognitive Dysfunction/diagnosis , Hypertension/complications , Cross-Sectional Studies , Risk Factors , Ecuador , Cognitive Dysfunction/etiology , Cognitive Dysfunction/epidemiology
10.
Gates Open Res ; 3: 1477, 2019.
Article in English | MEDLINE | ID: mdl-31410396

ABSTRACT

Despite years of effort, reliable biometric identification of newborns and young children has remained elusive. In this paper, we review the importance of trusted identification methods, the biometric landscape for infants and adults, barriers and success stories, and we discuss specific failure modes particular to young children. We then describe our approach to infant identification using non-contact optical imaging of fingerprints. We detail our technology development history, including Human-Centered Design methods, various iterations of our platform, and how these iterations addressed failure modes in the identification process. We close with a brief description of our clinical trial of newborns and infants at an urban hospital in Mexico and report preliminary results that show high accuracy, with matching rates consistent with acceptable field-performance for reliable biometric identification in large populations.

11.
Arch. cardiol. Méx ; 88(4): 287-297, oct.-dic. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-1124150

ABSTRACT

Resumen Introducción: Se revisará la evolución del tratamiento farmacológico de la insuficiencia cardiaca (IC) en los últimos 25 an˜os, desde el concepto de tratamiento con vasodilatadores, pasando por el bloqueo o inhibición del sistema renina-angiotensina-aldosterona y la inhibición betaadrenérgica y su importante contribución en la disminución de la morbimortalidad por IC, el papel de los péptidos natriuréticos y, finalmente, se conocerá uno de los estudios más importantes en el área cardiológica y específicamente en el manejo de la IC, en el cual se demuestra un enfoque modulador de los sistemas neuro humorales que se activan en estos pacientes. Objetivos: La IC constituye la etapa final de la mayoría de las enfermedades cardiovasculares, con una alta tasa de hospitalización y de morbimortalidad cardiovascular, siendo, por lo tanto, de interés constante la necesidad de encontrar un agente terapéutico innovador que disminuya significativamente estas complicaciones y también que mejore la calidad de vida de los que la presentan. Metodología: Se realizará una descripción del PARADIGM-HF Clinical Trial, que utilizó un compuesto sacubitrilo/valsartán para el manejo de la IC con un mecanismo modulador diferente del concepto de bloqueador de sistemas deletéreos que se activan cuando un paciente presenta síntomas y signos de IC. Conclusiones: La muerte por causas cardiovasculares u hospitalización por IC (el punto final primario) se produjo en 914 pacientes (21.8%) en el grupo sacubitrilo/valsartán y 1,117 pacientes (26.5%) en el grupo de enalapril (razón de riesgo en el grupo sacubitrilo/valsartán, 0.80; intervalo de confianza (IC) del 95%: 0.73 a 0.87; p < 0.001 (exacta p = 4.0 × 10 - 7)). De los pacientes que recibieron sacubitrilo/valsartán, 537 (12.8%) fueron hospitalizados por IC, en comparación con los 658 pacientes (15.6%) que recibieron enalapril (razón de riesgo, 0.79; IC del 95%, 0.71 a 0.89; p < 0.001). Un total de 711 pacientes (17.0%) en el grupo sacubitrilo/valsartán y 835 pacientes (19.8%) en el grupo de enalapril murió (razón de riesgo de muerte por cualquier causa, 0.84; IC del 95%, 0.76 a la 0.93; p < 0.001).


Abstract Introduction: A review is presented on the evolution of the pharmacological treatment of heart failure (HF) in the last 25 years, from the concept of treatment with vasodilators to the blocking or inhibition of the renin angiotensin aldosterone system. Beta-adrenergic inhibition and its important contribution in the reduction of morbidity and mortality due to HF will be discussed along with the role of the natriuretic peptides. One of the most important studies in the cardiology area, and specifically in the management of HF, is presented, in which an approach is demonstrated of the modulator of the neurohumoral systems that are activated in these patients. Objectives: HF is the final stage of most cardiovascular diseases, and has a high rate of hospital admission, as well as cardiovascular morbidity and mortality. Therefore, there is constant interest in the need to find an innovative therapeutic agent that significantly reduces these complications and that improves the quality of life of those who suffer from it. Methods: A description will be presented of the PARADIGM-HF Clinical Trial using a sacubitril/valsartán compound for the management of HF with a modulating mechanism different from the concept of a deleterious system blocker that is activated when a patient has symptoms and signs of heart failure. Conclusions: Death due to cardiovascular causes, or hospital admission due to heart failure (the primary endpoint) occurred in 914 patients (21.8%) in the Sacubitril / valsartán group, and 1117 patients (26.5%) in the enalapril group (risk ratio in the sacubitril / valsartán group, 0.80, with a 95% confidence interval [CI]: 0.73 to 0.87, P<0.001 ;exact P= 4.0 × 10 --7;). Of the patients receiving sacubitril / valsartán, 537 (12.8%) were hospitalised due to heart failure, compared with 658 patients (15.6%) receiving enalapril (hazard ratio 0.79, 95% CI: 0.71 to 0.89, P<.001). A total of 711 patients (17.0%) in the sacubitril / valsartán group, and 835 patients (19.8%) in the enalapril group, died (all-cause death rate, 0.84, 95% CI: 0.76 to 0.93, P<.001)


Subject(s)
Humans , Tetrazoles/therapeutic use , Enalapril/therapeutic use , Aminobutyrates/therapeutic use , Heart Failure/drug therapy , Quality of Life , Systole , Tetrazoles/pharmacology , Biphenyl Compounds , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Enalapril/pharmacology , Drug Combinations , Angiotensin Receptor Antagonists/therapeutic use , Angiotensin Receptor Antagonists/pharmacology , Valsartan , Aminobutyrates/pharmacology , Heart Failure/physiopathology , Hospitalization/statistics & numerical data
12.
Arch Cardiol Mex ; 88(4): 287-297, 2018.
Article in Spanish | MEDLINE | ID: mdl-29501368

ABSTRACT

INTRODUCTION: A review is presented on the evolution of the pharmacological treatment of heart failure (HF) in the last 25 years, from the concept of treatment with vasodilators to the blocking or inhibition of the renin angiotensin aldosterone system. Beta-adrenergic inhibition and its important contribution in the reduction of morbidity and mortality due to HF will be discussed along with the role of the natriuretic peptides. One of the most important studies in the cardiology area, and specifically in the management of HF, is presented, in which an approach is demonstrated of the modulator of the neurohumoral systems that are activated in these patients. OBJECTIVES: HF is the final stage of most cardiovascular diseases, and has a high rate of hospital admission, as well as cardiovascular morbidity and mortality. Therefore, there is constant interest in the need to find an innovative therapeutic agent that significantly reduces these complications and that improves the quality of life of those who suffer from it. METHODS: A description will be presented of the PARADIGM-HF Clinical Trial using a sacubitril/valsartán compound for the management of HF with a modulating mechanism different from the concept of a deleterious system blocker that is activated when a patient has symptoms and signs of heart failure. CONCLUSIONS: Death due to cardiovascular causes, or hospital admission due to heart failure (the primary endpoint) occurred in 914 patients (21.8%) in the Sacubitril / valsartán group, and 1117 patients (26.5%) in the enalapril group (risk ratio in the sacubitril / valsartán group, 0.80, with a 95% confidence interval [CI]: 0.73 to 0.87, P<0.001 [exact P= 4.0 × 10 - 7]). Of the patients receiving sacubitril / valsartán, 537 (12.8%) were hospitalised due to heart failure, compared with 658 patients (15.6%) receiving enalapril (hazard ratio 0.79, 95% CI: 0.71 to 0.89, P<.001). A total of 711 patients (17.0%) in the sacubitril / valsartán group, and 835 patients (19.8%) in the enalapril group, died (all-cause death rate, 0.84, 95% CI: 0.76 to 0.93, P<.001).


Subject(s)
Aminobutyrates/therapeutic use , Enalapril/therapeutic use , Heart Failure/drug therapy , Tetrazoles/therapeutic use , Aminobutyrates/pharmacology , Angiotensin Receptor Antagonists/pharmacology , Angiotensin Receptor Antagonists/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Biphenyl Compounds , Drug Combinations , Enalapril/pharmacology , Heart Failure/mortality , Heart Failure/physiopathology , Hospitalization/statistics & numerical data , Humans , Quality of Life , Systole , Tetrazoles/pharmacology , Valsartan
13.
J Child Adolesc Trauma ; 11(2): 197-204, 2018 Jun.
Article in English | MEDLINE | ID: mdl-32318150

ABSTRACT

In this study, we compare Portuguese and Cape Verdean youths' upholding of traditional beliefs about intimate partner violence (IPV) and the frequency of self-reported violent behavior in dating relationships. The sample (n = 404) consisted of 183 Cape Verdean and 221 Portuguese secondary school students of both sexes (56 % female; mean age = 16). We used two questionnaires that had previously been validated in the Portuguese population. The results revealed that young Cape Verdean adolescents uphold stronger traditional beliefs than Portuguese adolescents do, but there were no differences in overall prevalence of abuse between the two samples. The relationship between traditional beliefs and self-reported violence was significant only in the Cape Verdean sample, suggesting that campaigns against IPV have not, so far, been as effective in Cape Verde as in Portugal.

14.
Org Biomol Chem ; 14(10): 2930-7, 2016 Mar 14.
Article in English | MEDLINE | ID: mdl-26871309

ABSTRACT

Different electron-rich dienophiles were combined with the imine obtained from 2,4-O-benzylidene-d-erythrose and p-anisidine furnishing enantiomerically pure tetrahydroquinolines, by inverse electron-demand [4π + 2π] cycloaddition. The imine was also reacted with 2-substituted electron-rich 1,3-butadienes giving the diastereomeric pure product, resulting from the normal electron demand cycloaddition. The facial selectivity of both processes is proposed on the basis of a 1,4-relationship between the hydroxyl group and the nitrogen atom in the chiral N-(p-methoxyphenyl)imine derivative.


Subject(s)
Cycloaddition Reaction , Imines/chemistry , Quinolines/chemistry , Models, Molecular , Spectrometry, Mass, Electrospray Ionization
15.
Psicol. reflex. crit ; 28(4): 718-727, out.-dez. 2015. tab
Article in Portuguese | LILACS, Index Psychology - journals | ID: lil-763113

ABSTRACT

ResumoA Escala de Condutas Antissociais e Delitivas tem vindo a ser usada em vários países como uma medida comportamental do desvio juvenil, evidenciando resultados muito consistentes. Este artigo apresenta e discute a análise da validade empírica da estrutura fatorial da sua versão Portuguesa. A amostra foi constituída por 443 estudantes, 305 do sexo feminino e 138 do sexo masculino, com idades compreendidas entre os 15 e os 23 anos de idade (M = 14,8; DP = 1,90; Mo = 20), maioritariamente de nacionalidade portuguesa (92,1%). Em 60,6% dos casos os/as estudantes frequentavam a universidade. Os resultados sugerem a adequação psicométrica do instrumento, corroborando a estrutura bifatorial proposta em estudos prévios. São discutidas as potencialidades da utilização do instrumento em Portugal (AU).


AbstractThe Scale of Antisocial and Criminal Conducts has been used in several countries as a behavioral measure, showing very consistent results. This paper presents and discusses the analysis of the empirical validity of the factorial structure of its Portuguese version. The sample was comprised of 443 students, 305 female and 138 male, aged between 15 and 23 years (M = 14.8; SD = 1.90; Mo = 20), mostly Portuguese (92%), and 60.6% were college students. Results suggest the psychometric adequacy of instrument, confirming the bi-factorial structure proposed in previous studies. Advantages of its use with the Portuguese population are discussed (AU).


Subject(s)
Humans , Male , Female , Adolescent , Adult , Reproducibility of Results , Juvenile Delinquency , Antisocial Personality Disorder/diagnosis , Portugal , Psychometrics , Surveys and Questionnaires
16.
Vila Nova de Famalicão; Húmus; 2014. 173 p.
Monography in Portuguese | Sec. Est. Saúde SP, SESSP-ISPROD, Sec. Est. Saúde SP, SESSP-ISACERVO | ID: biblio-1081884
17.
Bioorg Chem ; 57: 148-154, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25462991

ABSTRACT

A range of novel pyridine 2,4,6-tricarbohydrazide derivatives (4a-4h) were synthesized and its biological inhibition towards α- and ß-glucosidases was studied. Most of the compounds demonstrate to be active against α-glucosidase, and quite inactive/completely inactive against ß-glucosidase. A number of compounds were found to be more active against α-glucosidase than the reference compound acarbose (IC50 38.25±0.12µM); being compound 4d with the p-hydroxy phenyl motive the most active (IC50 20.24±0.72µM). Molecular modeling studies show the interactions of compound 4d with the active site of target α-glucosidase kinase.


Subject(s)
Glycoside Hydrolase Inhibitors/chemistry , Glycoside Hydrolase Inhibitors/pharmacology , Pyridines/chemistry , Pyridines/pharmacology , Humans , Prunus/enzymology , Saccharomyces cerevisiae/enzymology , alpha-Glucosidases/chemistry , alpha-Glucosidases/metabolism , beta-Glucosidase/antagonists & inhibitors , beta-Glucosidase/chemistry , beta-Glucosidase/metabolism
18.
Carbohydr Res ; 395: 52-7, 2014 Aug 18.
Article in English | MEDLINE | ID: mdl-25043741

ABSTRACT

1-N-Carboxamide 1-azafagomines and 5-epi-1-azafagomines were obtained from 1-azafagomine and 5-epi-1-azafagomine. The hydroxyl groups and the N-2 pyridazine position were protected prior to reaction with different isocyanates to form ureas. Protective groups were removed leading to the target compounds in 18-23% global yields. Final compounds were tested towards α- and ß-glucosidases.


Subject(s)
Glycoside Hydrolase Inhibitors/chemistry , Indolizines/chemistry , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , alpha-Glucosidases/chemistry , beta-Glucosidase/antagonists & inhibitors , Glycoside Hydrolase Inhibitors/chemical synthesis , Indolizines/chemical synthesis , Isocyanates/chemistry , Saccharomyces cerevisiae/chemistry , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/isolation & purification , Stereoisomerism , Urea/chemistry , alpha-Glucosidases/isolation & purification , beta-Glucosidase/chemistry , beta-Glucosidase/isolation & purification
19.
Medwave ; 12(4)mayo 2012. tab
Article in Spanish | LILACS | ID: lil-715812

ABSTRACT

Introducción: el primer nacimiento es un acontecimiento en la vida de las personas y por lo tanto en su proceso de desarrollo. Las implicaciones que se derivan de imponer cambios en muchos niveles diferentes requieren respuestas diferentes de los padres. Esta situación vuelve pertinente el estudiar los problemas de los padres en el cuidado de los lactantes durante los primeros meses de vida. Objetivo: determinar las características socio-demográficas de los padres de niños con un mes de vida e identificar las dificultades los padres en el cuidado de los lactantes durante los primeros meses de vida. Material y Método: estudio transversal, no experimental, descriptivo, que consiste en una muestra no probabilística de 88 padres de recién nacidos durante los primeros meses de vida. Un cuestionario fue aplicado en dos partes, la primera consiste en una configuración socio-demográfica y obstétrica. La segunda parte se aplicó para determinar las dificultades de los padres en el cuidado de los lactantes durante los primeros meses de vida. Resultado y discusión: se encontró que las dificultades experimentadas por los padres en el cuidado de los lactantes durante los primeros meses de vida, se relacionan principalmente con las situaciones de la lactancia materna, con el indicador "saber qué hacer para cuidar/prevenir 'erupción' en el pezón"; los movimientos intestinales y el tamaño de la vejiga o "saber cómo actuar en situaciones de diarrea o estreñimiento"; y el nivel de la seguridad y la prevención de accidentes, cuyo indicador es "saber cómo se comportan/actuar cuando el bebé se ahoga". Es imprescindible conocer los problemas de los padres durante los primeros meses de vida, por lo que se puede promover una mejor adaptación a sus nuevos roles y desarrollar mejor las habilidades de los padres en el cuidado del recién nacido.


Introducción: o nascimento do primeiro filho é um acontecimento marcante na vida dos indivíduos e, consequentemente, no seu processo de desenvolvimento. As implicações que daí advêm impõem mudanças aos mais diferentes níveis e exigem respostas variadas por parte dos pais. Pelo que julgámos pertinente estudar as dificuldades dos pais no cuidar do RN durante o primeiro mês de vida. Objetivos: determinar as características sócio-demográficas dos pais do RN com um mês de vida e identificar as dificuldades dos pais no cuidar do RN durante o primeiro mês de vida. Material y Método: estudo transversal, não experimental, descritivo constituído por uma amostra não probabilística por conveniência de 88 pais de recém-nascidos durante o primeiro mês de vida. Foi aplicado um questionário composto por duas partes, uma primeira parte constituída por dados sócio-demográficos e contextos obstétricos e uma segunda parte pelas dificuldades dos pais no cuidar do RN durante o primeiro mês de vida. Resultado y discusión: constatámos que as dificuldades sentidas pelos pais no cuidar do RN durante o primeiro mês de vida, se situavam primordialmente ao nível do indicador ‘pega do mamilo’ da dimensão aleitamento materno, do indicador ‘saber como agir para cuidar/prevenir as “assaduras”’, da dimensão eliminação vesical, do indicador ‘saber como agir em situação de diarreia ou prisão de ventre’ da dimensão eliminação intestinal e do indicador ‘saber como agir/actuar quando o bebé se engasga’ da dimensão segurança e prevenção de acidentes. Torna-se imperioso conhecer as dificuldades dos pais durante o primeiro mês de vida, para que se possa promover uma melhor adaptação aos seus novos papéis e desenvolver competências parentais no âmbito da prestação de cuidados ao RN.


Introduction: the first birth is an event in the life of people and therefore in their development process. The implications that stem from changes arising on many different levels require a variety of parental responses. This makes studying the problems of parents in the care of infants during the first months of life a relevant issue. Objective: to determine the socio-demographic characteristics of parents with a one month old child and to identify the difficulties parents face in caring for their infants during the first months of life. Materials and methods: cross-sectional study, experimental, descriptive, with a non probabilistic sample of 88 parents. A questionnaire was applied in two parts, the first consisting of a socio-demographic and obstetrical configuration. The second part was applied to determine the difficulties of parents in the care of infants during the first months of life. Results and discussion: the study identifies and describes the difficulties experienced by parents in the care of newborns. It is essential to know the problems of parents during the first months of life of their infants in order to promote better adaptation strategies for their new roles and to develop better parenting skills.


Subject(s)
Humans , Male , Adult , Female , Infant, Newborn , Infant , Infant Care , Parent-Child Relations , Cross-Sectional Studies , Health Knowledge, Attitudes, Practice , Parenting , Socioeconomic Factors , Surveys and Questionnaires
20.
J Org Chem ; 76(23): 9584-92, 2011 Dec 02.
Article in English | MEDLINE | ID: mdl-22017265

ABSTRACT

A new expeditious preparation of homochiral (-)-1-azafagomine and (+)-5-epi-1-azafagomine has been devised. Stoodley's diastereoselective cycloaddition of dienes bearing a 2,3,4,6-tetraacetyl glucosyl chiral auxiliary to 4-phenyl-1,2,4-triazole-3,5-dione was merged with Bols's protocol for functionalizing alkenes into molecules bearing a glucosyl framework. Homochiral (+)-5-epi-1-azafagomine was synthetized for the first time. Partial reductive cleavage of the phenyltriazolidinone moiety afforded new homochiral 1-N-phenyl carboxamide derivatives of 1-azafagomine. Both enantiomers of these derivatives were synthetized and tested, displaying a very good enzymatic inhibition toward baker's yeast α-glucosidase. The molecular recognition mechanism of the 1-N-phenyl carboxamide derivative of 1-azafagomine by α-glucosidase from baker's yeast was studied by molecular modeling. The efficient packing of the aromatic ring of the 1-N-phenyl carboxamide moiety into a hydrophobic subsite (pocket) in the enzyme's active site seems to be responsible for the improved binding affinity in relation to underivatized (-)-1-azafagomine and (+)-1-azafagomine.


Subject(s)
Amides/chemistry , Enzyme Inhibitors/chemical synthesis , Indolizines/chemical synthesis , Binding Sites/drug effects , Crystallography, X-Ray , Cyclization , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Glycoside Hydrolases/antagonists & inhibitors , Indolizines/chemistry , Indolizines/pharmacology , Models, Molecular , Molecular Conformation , Stereoisomerism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...